Roger Aston
Chairman at RESP HEAL
Net worth: 114 074 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Leedman | M | - | 11 years | |
| Sam Wright | M | 46 | 18 years | |
| Tony Keating | M | - | 9 years | |
| Nigel Lange | M | - | 4 years | |
| Paul Brennan | M | 63 | 2 years | |
| Brenda Mary Shanahan | F | - | 17 years | |
| Darren M. Keamy | M | - | 19 years | |
| Jerry Kanellos | M | 61 | 9 years | |
| Steven Lydeamore | M | 56 | 2 years | |
| Travis Robins | M | - | - | |
| Stephen Anastasiou | M | 67 | 11 years | |
| Daniel Pollock | M | 64 | 12 years | |
| Philippe Wolgen | M | 61 | 19 years | |
| Richard Mollard | M | - |
Pitney Pharmaceuticals Pty Ltd.
 Pitney Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of PharmAust Ltd., Pitney Pharmaceuticals Pty Ltd. provides medical and pharmaceutical services. The private company is based in Kogarah, Australia. The CEO of the Australian company is Richard Mollard. Pitney Pharmaceuticals was acquired by PharmAust Ltd. on August 13, 2013 for $8.18 million. | - |
| David John Williams | M | 70 | 10 years | |
| Phillip Hains | M | 64 | 11 years | |
| Ravi Savarirayan | M | 57 | 7 years | |
| Michael Stein | M | 60 | 4 years | |
| Joanne Casey | M | 47 | - | |
| Jamie Joint | F | - | - | |
| Mike Connell | M | - | 3 years | |
| Scott Savage | M | - | 3 years | |
| Reza Moussakhani | M | - | 11 years | |
| Robert Charles Bishop | M | - | 11 years | |
| Christopher Ntoumenopoulos | M | - | 9 years | |
| Lachlan Hay | M | - | 17 years | |
| David Turner | M | - | 3 years | |
| Thomas Duthy | M | - | - | |
| Nicola Farley | F | 45 | 12 years | |
| Michael Thurn | M | - | 1 years | |
| Richard L. Faherty | M | 77 |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The private company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | - |
| Neville Bassett | M | - | 6 years | |
| Paul Hopper | M | 68 |
Biolife Science Ltd.
 Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Part of Imugene Ltd., Biolife Science Ltd. is an Australian company that manufactures cancer therapeutic vaccines. The private company is based in Brisbane, Australia. The company was founded by Brian Leedman. Biolife Science was acquired by Imugene Ltd. from Acuvax Ltd. on December 20, 2013 for $4.08 million. | - |
| Flavio Palumbo | M | 50 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nick Falzon | M | - | 4 years | |
| Craig Bottomley | M | - |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Aaron John Finlay | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Bryant McLarty | M | - | 10 years | |
| Roger Corbett | M | 81 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| David J. Sparling | M | 52 | 9 years | |
| Chris Roberts | M | 70 | 5 years | |
| Ron Best | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 13 years |
| John Martin | M | 62 | 10 years | |
| Graeme Roy Kaufman | M | 74 | 6 years | |
| Martin Frederick Rogers | M | 43 | - | |
| Stuart Mudge | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| David Parry | M | 70 |
The University of Manchester
| 7 years |
| Neil M. Frazer | M | 68 | 1 years | |
| Ian Frank Scholes | M | 69 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 15 years |
| Bruce Mathieson | M | 80 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 3 years |
| Yao Lee | M | 54 | 7 years | |
| John Bird | M | - | - | |
| Angelo Morella | M | - | - | |
| Grant Rawlin | M | - | 14 years | |
| Udantha Abeyratne | M | - | 5 years | |
| Martin Cross | M | - | 5 years | |
| Karl Pechmann | M | - | 3 years | |
| Margaret Kay Taylor | F | 64 | - | |
| Elane Zelcer | M | - | 4 years | |
| Amos Meltzer | M | 58 | - | |
| Steven Swinson | M | - |
The University of Manchester
| 4 years |
| Beverley June Hughes | F | 74 |
The University of Manchester
| 21 years |
| Peter Vaughan | M | 40 | 5 years | |
| David Morris | M | - | - | |
| Scott Richards | M | 60 | 10 years | |
| Jillian McGregor | F | - | - | |
| Dan Peres | M | - | 3 years | |
| Panos Andreas Loizou | M | 60 |
The University of Manchester
| 7 years |
| Okechukwu John Mbonu | M | 71 |
The University of Manchester
| 8 years |
| Peter Anastasiou | M | 63 | 6 years | |
| Thomas Liquard | M | 51 | 2 years | |
| Daniel Kenny | M | - | 6 years | |
| Ben Herbert | M | 56 | 7 years | |
| Richard Berman | M | 81 | 1 years | |
| Robert Johnston | M | - | 6 years | |
| Philip Powell | M | 65 | 6 years | |
| Lawrence John Wood | M | 87 | 6 years | |
| Alan Dunton | M | 70 | 2 years | |
| Otto Buttula | M | - | 2 years | |
| Gary Jacob | M | 77 | 2 years | |
| Geoffrey Norman Vaughan | M | 91 | 15 years | |
| Stewart Washer | M | 54 | 1 years | |
| Richard H. Irving | M | - |
The University of Manchester
| 6 years |
| Andrew Burgess | M | 55 |
Ascent Pharmahealth Pty Ltd.
 Ascent Pharmahealth Pty Ltd. Pharmaceuticals: MajorHealth Technology Ascent Pharmahealth Pty Ltd. manufactures and supplies generic pharmaceuticals. It offers skincare, private prescription medicine, and dermorganics. The company was founded by Dennis Bastas in December 2003 and is headquartered in Australia. | - |
| Simon O'Loughlin | M | 66 | 1 years | |
| John Chiplin | M | 66 | 3 years | |
| Wayne Best | M | - | 4 years | |
| Fung Man Wai | M | 75 |
The University of Manchester
| 4 years |
| Adam James Sierakowski | M | - | 3 years | |
| David Franklyn | M | 60 | 4 years | |
| Tom Milicevic | M | - | 4 years | |
| Mark Cansdale | M | - | 6 years | |
| Paul MacLeman | M | 58 | 4 years | |
| Lawrence Gozlan | M | 45 | 1 years | |
| Joseph M. Baini | M | 58 | 2 years | |
| Glen Richards | M | - | 5 years | |
| Robyn Elliott | M | 63 | 18 years | |
| Henry Gulev | M | - | 6 years | |
| Graeme N. Stevens | M | - | 6 years | |
| Wai Ching Wong | F | 63 |
The University of Manchester
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 91 | 91.00% |
| United Kingdom | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Roger Aston
- Personal Network
